Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery

Clinical trial NCT00838383 · COMPLETED

Trial details

NCT number: NCT00838383
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiac Surgery Subjects Subjects Undergoing CABG and/or Cardiac Valve Replacement

Start date: 2006-08-10
Primary completion: 2008-03-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.